For the study ... show. The findings were published Monday in the Annals of Internal Medicine. There has been a notable uptick in GLP-1 use since 2020, Rezaie noted. The U.S. Food and Drug ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

A new study is showing the effectiveness of GLP-1 medication, commonly referred to as weight loss drugs, and how they stack up against bariatric surgery. NBC medical contributor Dr. Natalie Azar joins ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, ...

Related Massive study looks at benefits, risks of GLP-1 weight-loss drugs GLP-1 medications show promise in slowing ... GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% in 2022.

WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...

For this study, researchers analyzed U.S. federal research data in which people were asked about their GLP-1 prescriptions. Results showed that among people without diabetes, GLP-1 drug use rose ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat ... said that “this study was helpful to show that some muscle can occur with significant ...

"This large cohort study represents a reassuring safety signal showing that GLP-1 drugs are not ... links between GLP-1 use and pancreatic cancer. And this just shows, as have other human studies ...